C-Level Q&As

Q&A With Malcolm Weir, Executive Vice Chairman of Sosei Heptares

01 November 2021
Join us as we sit down with Malcom Weir (Executive Vice Chairman, Sosei Heptares) to discuss the Drug Discovery landscape and recent therapeutic innovations.

Join us as we sit down with Malcom Weir (Executive Vice Chairman, Sosei Heptares) to discuss the Drug Discovery landscape and recent therapeutic innovations. This Q&A forms part of our CEO podcasts series, bringing you the latest insights from key industry leaders.

Share this article

Share on facebook
Share on twitter
Share on linkedin

You may also be interested in...

Panel Discussion
Join Steve Rees, Pieter Fokko Van Loo, and Vivek Vishnudas for a discussion on novel drug targets.
08 November 2021
Commentary
Covalent inhibitors have progressed significantly since they were discovered in the 18th century and are now experiencing a resurgence.
12 October 2021

Continue browsing

Share this article

Share on facebook
Share on twitter
Share on linkedin

Join our Discovery mailing list

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Drug Discovery

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.